Literature DB >> 26232615

Arginine vasopressin receptor signaling and functional outcomes in heart failure.

Melissa A Wasilewski1, Valerie D Myers2, Fabio A Recchia2, Arthur M Feldman2, Douglas G Tilley3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26232615      PMCID： PMC4972451          DOI： 10.1016/j.cellsig.2015.07.021

Source DB:  PubMed          Journal:  Cell Signal        ISSN： 0898-6568            Impact factor:   4.315


× No keyword cloud information.
  144 in total

1.  Brain vasopressin V(1) receptors contribute to enhanced cardiovascular responses to acute stress in chronically stressed rats and rats with myocardial infarcton.

Authors:  Agnieszka Cudnoch-Jedrzejewska; Ewa Szczepanska-Sadowska; Jakub Dobruch; Ryszard Gomolka; Liana Puchalska
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-12-30       Impact factor: 3.619

2.  Chronic administration of oral vasopressin type 2 receptor antagonist tolvaptan exerts both myocardial and renal protective effects in rats with hypertensive heart failure.

Authors:  Hanako Morooka; Yoshitaka Iwanaga; Yodo Tamaki; Toru Takase; Yasumitsu Akahoshi; Yoshimasa Nakano; Hiroyuki Fujiki; Shunichi Miyazaki
Journal:  Circ Heart Fail       Date:  2012-05-24       Impact factor: 8.790

3.  Down-regulation of V1a vasopressin receptors in the cerebellum after myocardial infarction.

Authors:  Elwira Milik; Ewa Szczepanska-Sadowska; Agnieszka Cudnoch-Jedrzejewska; Jakub Dobruch
Journal:  Neurosci Lett       Date:  2011-05-27       Impact factor: 3.046

4.  Inhibitory effect of cyclosporin A on growth and collagen synthesis of rat cardiac fibroblasts induced by arginine vasopressin.

Authors:  Fu-jun Shang; Lian-you Zhao; Qiang-sun Zheng; Jie-pin Wang
Journal:  Yao Xue Xue Bao       Date:  2006-11

Review 5.  Hyponatremia and heart failure--pathophysiology and implications.

Authors:  Domenic A Sica
Journal:  Congest Heart Fail       Date:  2005 Sep-Oct

6.  A randomised, double-blind, multi-centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the Emergency Department.

Authors:  Marcus Eng Hock Ong; Ling Tiah; Benjamin Sieu-Hon Leong; Elaine Ching Ching Tan; Victor Yeok Kein Ong; Elizabeth Ai Theng Tan; Bee Yen Poh; Pin Pin Pek; Yuming Chen
Journal:  Resuscitation       Date:  2012-02-18       Impact factor: 5.262

7.  Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease.

Authors:  Paolo Verdecchia; Peter Sleight; Giuseppe Mancia; Robert Fagard; Bruno Trimarco; Roland E Schmieder; Jae-Hyung Kim; Garry Jennings; Petr Jansky; Jyh-Hong Chen; Lisheng Liu; Peggy Gao; Jeffrey Probstfield; Koon Teo; Salim Yusuf
Journal:  Circulation       Date:  2009-09-21       Impact factor: 29.690

8.  The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure.

Authors:  M Packer
Journal:  J Am Coll Cardiol       Date:  1992-07       Impact factor: 24.094

9.  Effects of arginine vasopressin on growth of rat cardiac fibroblasts: role of V1 receptor.

Authors:  Xue-Dong Yang; Lian-You Zhao; Qiang-Sun Zheng; Xue Li
Journal:  J Cardiovasc Pharmacol       Date:  2003-07       Impact factor: 3.105

10.  Impaired arginine-vasopressin-induced aldosterone release from adrenal gland cells in mice lacking the vasopressin V1A receptor.

Authors:  Jun-ichi Birumachi; Masami Hiroyama; Yoko Fujiwara; Toshinori Aoyagi; Atsushi Sanbe; Akito Tanoue
Journal:  Eur J Pharmacol       Date:  2007-03-24       Impact factor: 4.432
View more
  15 in total

1.  Tuning excitability of the hypothalamus via glutamate and potassium channel coupling.

Authors:  David D Kline
Journal:  J Physiol       Date:  2017-06-09       Impact factor: 5.182

2.  Vasopressin type 1A receptor deletion enhances cardiac contractility, β-adrenergic receptor sensitivity and acute cardiac injury-induced dysfunction.

Authors:  Melissa A Wasilewski; Laurel A Grisanti; Jianliang Song; Rhonda L Carter; Ashley A Repas; Valerie D Myers; Erhe Gao; Walter J Koch; Joseph Y Cheung; Arthur M Feldman; Douglas G Tilley
Journal:  Clin Sci (Lond)       Date:  2016-09-02       Impact factor: 6.124

3.  Predictive Value of Plasma Copeptin Level in Children with Acute Heart Failure.

Authors:  Doaa El Amrousy; Dina Abdelhai; Mohammed Nassar
Journal:  Pediatr Cardiol       Date:  2022-05-09       Impact factor: 1.838

Review 4.  G-Protein-Coupled Receptors in Heart Disease.

Authors:  Jialu Wang; Clarice Gareri; Howard A Rockman
Journal:  Circ Res       Date:  2018-08-31       Impact factor: 17.367

Review 5.  Cardiovascular Neuroendocrinology: Emerging Role for Neurohypophyseal Hormones in Pathophysiology.

Authors:  Ato O Aikins; Dianna H Nguyen; Obed Paundralingga; George E Farmer; Caroline Gusson Shimoura; Courtney Brock; J Thomas Cunningham
Journal:  Endocrinology       Date:  2021-08-01       Impact factor: 4.736

6.  Sustained phospholipase C stimulation of H9c2 cardiomyoblasts by vasopressin induces an increase in CDP-diacylglycerol synthase 1 (CDS1) through protein kinase C and cFos.

Authors:  Nicholas J Blunsom; Evelyn Gomez-Espinosa; Tim G Ashlin; Shamshad Cockcroft
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2019-03-09       Impact factor: 4.698

7.  Role of PKC in the Regulation of the Human Kidney Chloride Channel ClC-Ka.

Authors:  Andrea Gerbino; Roberta De Zio; Daniela Russo; Luigi Milella; Serena Milano; Giuseppe Procino; Michael Pusch; Maria Svelto; Monica Carmosino
Journal:  Sci Rep       Date:  2020-06-24       Impact factor: 4.379

Review 8.  Obestatin as a key regulator of metabolism and cardiovascular function with emerging therapeutic potential for diabetes.

Authors:  Elaine Cowan; Kerry J Burch; Brian D Green; David J Grieve
Journal:  Br J Pharmacol       Date:  2016-05-27       Impact factor: 8.739

9.  Correlation between miRNA target site polymorphisms in the 3' UTR of AVPR1A and the risk of hypertension in the Chinese Han population.

Authors:  Liuping Zhang; Jinwei Liu; Peng Cheng; Fangchao Lv
Journal:  Biosci Rep       Date:  2019-05-14       Impact factor: 3.840

10.  Glucocorticoids Reverse Diluted Hyponatremia Through Inhibiting Arginine Vasopressin Pathway in Heart Failure Rats.

Authors:  Xiaoran Zhu; Yaomeng Huang; Shuyu Li; Ning Ge; Tongxin Li; Yu Wang; Kunshen Liu; Chao Liu
Journal:  J Am Heart Assoc       Date:  2020-05-09       Impact factor: 5.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.